LORAZEPAM AND ALPRAZOLAM: PERFORMANCE EFFECTS IN ELDERLY
LORAZEPAM AND ALPRAZOLAM: PERFORMANCE EFFECTS IN ELDERLY
批准号:
3381639
负责人:
Nunzio Pomara
金额:
$18.61万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-30 至 1994-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Because of their widespread use, the acute and chronic effects of
benzodiazepines on human performance are of considerable practical
significance. The effects on the elderly (aged 60 to 78 years) are of
particular concern since these individuals may be more sensitive to some of
the adverse central effects of benzodiazepines. Moreover, normal
age-related decline in cognitive functions may accentuate the significance
of drug-induced deficits.
Our current NIMH-sponsored study has found that diazepam, a benzodiazepine
with a long elimination half-life (t 1/2), produced profound memory and
psychomotor impairment after acute administration, and significant next-day
memory impairment following chronic bedtime administration in elderly
subjects. Moreover, only partial tolerance developed to the acute adverse
effects after chronic administration. While it is often assumed that
chronic treatment with benzodiazepines with shorter elimination half-lives
(which results in less drug accumulation) will, in general, be associated
with a smaller number of adverse effects on performance, there are few
systematic studies of the effects of these drugs on performance in the
elderly. Additionally, there are even fewer studies which include the very
elderly, a group which may be partially vulnerable to the adverse effects
of benzodiazepines. The aim of the proposed study is to assess the acute
and chronic effects on task performance of alprozolam and lorazepam, two
commonly prescribed benzodiazepines with relatively short t 1/2s. More
specifically, this study is designed to answer the following questions:
1. What are the acute and chronic effects of alprazolam and lorazepam on
task performance in the elderly? Do the two drugs differ with respect to
these effects?
2. Within the elderly group, is increasing age associated with increased
adverse effects on task performance?
3. What is the relationship between the magnitude of drug-induced
impairment and drug plasma concentration?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Depression treatment and Aβ dynamics: A study of Alzheimer’s disease risk
-
批准号:10468212
-
项目类别:
-
资助金额:$79.45万
-
财政年份:2021
-
负责人:Nunzio Pomara
-
依托单位:
Depression treatment and Aβ dynamics: A study of Alzheimer’s disease risk
-
批准号:10301716
-
项目类别:
-
资助金额:$78.51万
-
财政年份:2021
-
负责人:Nunzio Pomara
-
依托单位:
Depression treatment and Aβ dynamics: A study of Alzheimer’s disease risk
-
批准号:10681339
-
项目类别:
-
资助金额:$78.24万
-
财政年份:2021
-
负责人:Nunzio Pomara
-
依托单位:
Plasma and CSF Abeta peptides in late-onset major depression
-
批准号:8033160
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2007
-
负责人:Nunzio Pomara
-
依托单位:
Plasma and CSF Abeta peptides in late-onset major depression
-
批准号:7208814
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2007
-
负责人:Nunzio Pomara
-
依托单位:
Plasma and CSF Abeta peptides in late-onset major depression
-
批准号:7568991
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2007
-
负责人:Nunzio Pomara
-
依托单位:
Plasma and CSF Abeta peptides in late-onset major depression
-
批准号:7781322
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2007
-
负责人:Nunzio Pomara
-
依托单位:
LONGTERM LORAZEPAM USE AND ACUTE TOXICITY IN THE ELDERLY
-
批准号:7605694
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2007
-
负责人:Nunzio Pomara
-
依托单位:
LONGTERM LORAZEPAM USE AND ACUTE TOXICITY IN THE ELDERLY
-
批准号:7378260
-
项目类别:
-
资助金额:$1.54万
-
财政年份:2006
-
负责人:Nunzio Pomara
-
依托单位:
LONGTERM LORAZEPAM USE AND ACUTE TOXICITY IN THE ELDERLY
-
批准号:7207080
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2005
-
负责人:Nunzio Pomara
-
依托单位:
Longterm Lorazepam Use and Acute Toxicity in the Elderly
-
批准号:6974298
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2004
-
负责人:Nunzio Pomara
-
依托单位:
LONG-TERM LORAZEPAM USE AND ACUTE TOXICITY IN THE AGED
-
批准号:6499284
-
项目类别:
-
资助金额:$26.65万
-
财政年份:2001
-
负责人:Nunzio Pomara
-
依托单位:
LONG-TERM LORAZEPAM USE AND ACUTE TOXICITY IN THE AGED
-
批准号:6841930
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2001
-
负责人:Nunzio Pomara
-
依托单位:
LONG-TERM LORAZEPAM USE AND ACUTE TOXICITY IN THE AGED
-
批准号:6697520
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2001
-
负责人:Nunzio Pomara
-
依托单位:
LONG-TERM LORAZEPAM USE AND ACUTE TOXICITY IN THE AGED
-
批准号:6629223
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2001
-
负责人:Nunzio Pomara
-
依托单位:
LONG-TERM LORAZEPAM USE AND ACUTE TOXICITY IN THE AGED
-
批准号:6287040
-
项目类别:
-
资助金额:$28.65万
-
财政年份:2001
-
负责人:Nunzio Pomara
-
依托单位:
APOE E4 AND LORAZEPAM EFFECTS ON ELDERLY
-
批准号:2035629
-
项目类别:
-
资助金额:$30.48万
-
财政年份:1997
-
负责人:Nunzio Pomara
-
依托单位:
APOE E4 AND LORAZEPAM EFFECTS ON ELDERLY
-
批准号:2890923
-
项目类别:
-
资助金额:$18.66万
-
财政年份:1997
-
负责人:Nunzio Pomara
-
依托单位:
APOE E4 AND LORAZEPAM EFFECTS ON ELDERLY
-
批准号:2675619
-
项目类别:
-
资助金额:$30.62万
-
财政年份:1997
-
负责人:Nunzio Pomara
-
依托单位:
LORAZEPAM AND ALPRAZOLAM: PERFORMANCE EFFECTS IN ELDERLY
-
批准号:2245460
-
项目类别:
-
资助金额:$19.95万
-
财政年份:1991
-
负责人:Nunzio Pomara
-
依托单位:
海外基金